Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)

Objective To compare the efficacy and safety of 1470-nm diode laser enucleation of the prostate (DiLEP) with that of plasmakinetic resection of the prostate (PKRP) in treating patients with large benign prostatic hyperplasia (BPH > 80ml).Methods The clinical data from 211 cases of BPH (>80 ml)...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Xiao, Xiao Maolin, Xiong Tao, Deng Xiaohong, Wang Jinzhong, Tong Wei, Chen Gaoliang, Tang Mengxi
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:The Aging Male
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13685538.2023.2257307
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059264529268736
author Xiao Xiao
Xiao Maolin
Xiong Tao
Deng Xiaohong
Wang Jinzhong
Tong Wei
Chen Gaoliang
Tang Mengxi
author_facet Xiao Xiao
Xiao Maolin
Xiong Tao
Deng Xiaohong
Wang Jinzhong
Tong Wei
Chen Gaoliang
Tang Mengxi
author_sort Xiao Xiao
collection DOAJ
description Objective To compare the efficacy and safety of 1470-nm diode laser enucleation of the prostate (DiLEP) with that of plasmakinetic resection of the prostate (PKRP) in treating patients with large benign prostatic hyperplasia (BPH > 80ml).Methods The clinical data from 211 cases of BPH (>80 ml) were collected for analysis. The patients were divided into two groups: the PKRP group (n = 118) and the DiLEP group (n = 93), based on the surgical method used.Result The DiLEP group demonstrated significantly lower surgical time (p < 0.001), intraoperative bleeding (p < 0.001), bladder flushing time (p = 0.003), indwelling catheter time (p < 0.005), and length of hospital stay (p = 0.018) compared to the PKRP group. However, the quality of the prostatectomy was significantly higher in the DiLEP group (p = 0.005). The Qmax for the DiLEP group was significantly higher than that of the PKRP group (p < 0.05). Compared to the PKRP group, the incidence of urinary incontinence in the DiLEP group increased significantly 4 weeks post-surgery (p = 0.026), although the need for blood transfusion during surgery was significantly reduced (p = 0.037).Conclusion Both DiLEP and PKRP are safe and effective methods for treating large-volume BPH. However, DiLEP offers advantages such as more thorough glandular resection, shorter surgical time, reduced bleeding, quicker recovery, and fewer complications.
format Article
id doaj-art-e136eb48327c4dfd9b2d174f086a6b15
institution DOAJ
issn 1368-5538
1473-0790
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series The Aging Male
spelling doaj-art-e136eb48327c4dfd9b2d174f086a6b152025-08-20T02:50:56ZengTaylor & Francis GroupThe Aging Male1368-55381473-07902024-12-0127110.1080/13685538.2023.2257307Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)Xiao Xiao0Xiao Maolin1Xiong Tao2Deng Xiaohong3Wang Jinzhong4Tong Wei5Chen Gaoliang6Tang Mengxi7Department of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, The People’s Hospital of Rongchang District, Chongqing, ChinaDepartment of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, Chongqing General Hospital, Chongqing, ChinaDepartment of Urology, The People’s Hospital of Rongchang District, Chongqing, ChinaObjective To compare the efficacy and safety of 1470-nm diode laser enucleation of the prostate (DiLEP) with that of plasmakinetic resection of the prostate (PKRP) in treating patients with large benign prostatic hyperplasia (BPH > 80ml).Methods The clinical data from 211 cases of BPH (>80 ml) were collected for analysis. The patients were divided into two groups: the PKRP group (n = 118) and the DiLEP group (n = 93), based on the surgical method used.Result The DiLEP group demonstrated significantly lower surgical time (p < 0.001), intraoperative bleeding (p < 0.001), bladder flushing time (p = 0.003), indwelling catheter time (p < 0.005), and length of hospital stay (p = 0.018) compared to the PKRP group. However, the quality of the prostatectomy was significantly higher in the DiLEP group (p = 0.005). The Qmax for the DiLEP group was significantly higher than that of the PKRP group (p < 0.05). Compared to the PKRP group, the incidence of urinary incontinence in the DiLEP group increased significantly 4 weeks post-surgery (p = 0.026), although the need for blood transfusion during surgery was significantly reduced (p = 0.037).Conclusion Both DiLEP and PKRP are safe and effective methods for treating large-volume BPH. However, DiLEP offers advantages such as more thorough glandular resection, shorter surgical time, reduced bleeding, quicker recovery, and fewer complications.https://www.tandfonline.com/doi/10.1080/13685538.2023.2257307Prostate hyperplasia1470-nm semiconductor laserPKRPcomplicationssafety
spellingShingle Xiao Xiao
Xiao Maolin
Xiong Tao
Deng Xiaohong
Wang Jinzhong
Tong Wei
Chen Gaoliang
Tang Mengxi
Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
The Aging Male
Prostate hyperplasia
1470-nm semiconductor laser
PKRP
complications
safety
title Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
title_full Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
title_fullStr Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
title_full_unstemmed Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
title_short Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml)
title_sort comparative analysis of the safety and efficacy of 1470 nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia 80 ml
topic Prostate hyperplasia
1470-nm semiconductor laser
PKRP
complications
safety
url https://www.tandfonline.com/doi/10.1080/13685538.2023.2257307
work_keys_str_mv AT xiaoxiao comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT xiaomaolin comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT xiongtao comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT dengxiaohong comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT wangjinzhong comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT tongwei comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT chengaoliang comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml
AT tangmengxi comparativeanalysisofthesafetyandefficacyof1470nmdiodelaserenucleationoftheprostateandplasmakineticresectionofprostateinthetreatmentoflargevolumebenignprostatichyperplasia80ml